Dr Kaylee Slater is a Postdoctoral Research Fellow and at the University of Sydney, with a strong focus on cardiovascular disease prevention and blood pressure management. Kaylee has led and contributed to numerous co-design and consumer involvement projects, developing patient education strategies tailored to diverse populations. Her research spans the care continuum, exploring hypertension management from both patient and healthcare professional perspectives. Kaylee uses qualitative methods to understand lived experiences and systemic barriers, informing evidence-based interventions. Her work integrates patient voices into clinical and educational frameworks, aiming to improve outcomes and engagement in primary care. Additionally, her current research includes a randomised controlled trial to improve blood pressure care in pharmacies and sex-specific blood pressure education for high risk women. She is also an Accredited Practising Dietitian with clinical experience in fertility and pregnancy nutrition.

Dr. Ross Tsuyuki is a Professor of Medicine (Cardiology) and Director of the EPICORE Centre (a health research coordinating centre) at the University of Alberta and is the Editor-in-Chief of the Canadian Pharmacists Journal. Having previously served on Hypertension Canada’s Board of Directors, Dr. Tsuyuki was elected in 2019 and appointed Vice-President. He also serves as a Chair of the Education & Implementation Committee and is a member of the Hypertension Canada Guidelines Committee. Dr. Tsuyuki’s interests are in clinical trials design and execution, hypertension, heart failure, community practice-based research, cardiovascular risk factors, and in the provision of support for clinical researchers through the EPIRCORE Centre. Dr. Tsuyuki has received several awards for teaching, as well as an appointment as a Fellow of the Canadian Society of Hospital Pharmacists, the American College of Cardiology and the Canadian Academy of Health Sciences. In 2005, he was recognized as the Canadian Pharmacist of the Year by the Canadian Pharmacists Association and the International Society of Hypertension.

Dr. Shiva Raj Mishra is a global health researcher and epidemiologist specializing in cardiovascular health, health equity, and implementation science. Currently a Senior Research Fellow at the School of Medicine, Western Sydney University, he focuses on cardiovascular prevention and management at the primary care and community settings. Dr. Mishra earned his PhD in Epidemiology from the University of Queensland, where he was a Global Change Scholar. His research integrates causal inference, health data science, and policy evaluation, with a focus on low-income settings. Dr. Mishra has held positions at the University of Melbourne and served as a visiting scholar at Harvard Medical School. He is also affiliated with the Nepal Development Society and the World Heart Federation. Driven by personal experiences with non-communicable diseases in his family, Dr. Mishra is committed to advancing equitable healthcare solutions globally.

Dr. Riana Rahmawati, PhD, is a lecturer at the Faculty of Medicine, Universitas Islam Indonesia, Yogyakarta, Indonesia. She earned her medical degree and a master’s degree in Drug Management and Policy from Universitas Gadjah Mada and completed her PhD in Pharmacy at the University of Technology Sydney. Her research focuses on medication adherence among hypertensive older adults and on community-based programs supporting chronic disease management, with numerous publications in esteemed journals and books. She is actively committed to enhancing medication literacy, adherence, and hypertension management in Indonesia, especially among the older adult population.

Gautam Satheesh is a PhD candidate at the Faculty of Medicine and Health, University of Sydney, and a researcher at The George Institute for Global Health in Sydney. His doctoral research focuses on strengthening team-based care for hypertension in Australia, with particular emphasis on enhancing the roles of nurses and pharmacists in supporting evidence-based blood pressure management. His work applies mixed methods and implementation science approaches to explore provider perspectives, workforce modelling, and system-level reforms that can expand access and equity in hypertension care. Gautam has also contributed to global policy efforts, including the World Heart Federation’s efforts on Single Pill Combinations and the WHO HEARTS technical package on hypertension control. His broader research interests span cardiovascular disease prevention, access to essential medicines, and innovative service delivery models in low- and middle-income countries. He is passionate about building evidence that bridges clinical practice, health systems, and policy for population-level impact.

Jennifer Irvine is an education-focused lecturer in the Department of Pharmacology at Monash University.

Associate Professor Nicole Jones is the head of the Neuropharmacology and Brain Injury group in School of Biomedical Sciences (SBMS) and Associate Dean of Postgraduate Research Training in Faculty of Medicine and Health at UNSW, Sydney. She completed her PhD in Pharmacology at Monash University (Melbourne), and postdoctoral fellowships at Eli Lilly (UK and USA) and the Howard Florey Institute (Melbourne). Since 2008, she has been a leading Neuroscience and Pharmacology educator across different programs in SBMS (Neuropharmacology, Drug Discovery, Design and Development), demonstrating impact through the design and implementation of innovative teaching initiatives to motivate and engage students, resulting in enhanced student outcomes.

Nilushi Karunaratne is a dynamic Education-focused academic specialising in skill-based instruction and innovative teaching practices in physiology and pharmacology. Her education research spans building core pharmacology knowledge and essential skills, as well as exploring teamwork and resilience skill-based instruction to support students in contemporary educational landscapes.

Dr Johnson Liu is a Senior Lecturer and education-focused academic in the Department of Pharmacology, School of Biomedical Sciences, Faculty of Medicine & Health, UNSW Sydney. He holds a BSc, MSc, and PhD in Pharmacology, and has previously held academic positions at South China Agricultural University, the University of Auckland, AUT University and the University of Tasmania. He teaches pharmacology-related subjects across medicine, biomedicine and pharmaceutical science programs, serving as Course Convenor and Program Academic Coordinator. His research interests span anticancer drug discovery and development, pharmacokinetics, drug transporters, and chemotherapy-induced neuropathy. He also pursues pedagogical research, focusing on core concept mapping and virtual reality application in pharmacology education, supported by funding from reputable organizations. Dr Liu has supervised Honours, Masters and PhD students, and has published over 50 research articles. He also contributes to the academic community as a review editor and expert reviewer for international journals.

Slade Matthews is a researcher and educator whose career has been marked by his dedication to the intersection of biomedical science and machine learning. He is committed to fostering mathematical literacy among students and has made contributions to both research and education in the field. He holds two teaching awards for university teaching. Recognizing the importance of effective pedagogy, Slade completed a Graduate Certificate in Higher Education in 2011. He has a Bachelor of Medical Science, Honours (1995) which included an investigation into the venom of the Australian copperhead snake using classical pharmacological bioassays, chromatography, and electrophysiology. His doctoral research (PhD 2007) focussed on the integration of machine learning techniques for cell classification tasks and modelling relationships in clinical data. Slade's primary research focus centres on the fusion of experimental design, statistical analysis, and machine learning to investigate biomedical problems, especially in toxicology. He has published 43 publications in peer-reviewed journals and has been cited 1275 times.

Slade is a researcher and educator in both pharmacology and toxicology at the University of Sydney School of Pharmacy. His BmedSci (Hons), 1995, included an investigation of copperhead snake venom using classical pharmacological bioassays, chromatography, and electrophysiology. His doctoral research (PhD 2007) focused on the integration of machine learning techniques for cell classification tasks and modelling clinical outcomes in clinical data. He also holds two educational qualifications: a DipEd and a GradCertEd (HigherEd). Slade’s primary research focus is computational toxicology – a fusion of experimental design, statistical analysis, and machine learning. He serves as representative pharmacologist on NSW Health, Poisons Advisory (statutory) Committee and is also an external assessor for TGA Therapeutic Goods Evaluation Panel and also collaborates with AICIS on computational Ames-assay models for mutagenicity chemical assessment. He is Deputy Chair of the ASCEPT Toxicology Special Interest Group and contributes to ASCEPT’s official responses to TGA requests for consultation.

Tamara is an Associate Professor and Assistant Associate Dean (Pharmaceutical Sciences) at the School of Health and Biomedical Sciences at RMIT University. She is an experienced academic with expertise in teaching pharmacology and physiology across a wide range of degree programs and to students with diverse backgrounds. She has a strong track record in leading large-scale curriculum reform, including curriculum mapping, review, design and development.

I am a Lecturer (Teaching Focused) in the Department of Physiology and Pharmacology at La Trobe University. I completed my PhD in the Department of Pharmacology at Monash University, where I investigated the cardiovascular effects of animal venoms. I have over eight years of experience delivering workshops, tutorials, and wet practicals to undergraduate science, allied health, and biomedical students. More recently, I have been involved in curriculum development for third-year pharmacology subjects, with a strong focus on creating student-centered content and embedding transferrable skills and knowledge. My passion is inspiring the next generation of STEM students to continue their education and explore research and STEM-related careers. I am also interested in lifelong learning and collaborating with colleagues on education research, particularly around how to retain student engagement and support long-term involvement in STEM courses.

Eryn Werry is a Senior Lecturer in Brain and Mind Sciences (Central Clinical School, Faculty of Medicine and Health) and Research Associate in the Drug Discovery Lab (School of Chemistry, Faculty of Science). She completed her PhD at the University of Sydney, studying glial cells, and then took up a Brain Sciences Postdoctoral Fellowship at UNSW, studying neurogenesis. Since 2012, she has been researching new therapeutics for brain diseases at the University of Sydney. She is also Program Director for the Master of Brain and Mind Sciences at the University of Sydney.

Course Coordinator for the Bachelor of Pharmacy(Honours) course at Curtin University in Western Australia, teaching physiology, biochemistry and pharmacology to Pharmacy and Biomedical Science students, while having a research program in understanding multi drug efflux systems using polarised rapid in vitro human models such as Caco-2 and CLEFF4, while also working on Iron and Copper depletion in cancer, infectious disease treatment, and drug distribution.

A/Prof Celine Valant is the co-leader of the Analytical and Structural Neuropharmacology group at Monash Institute of Pharmaceutical Sciences. She is internationally recognised for advancing the mechanistic understanding and therapeutic exploitation of G protein-coupled receptors (GPCRs), the largest family of drug targets. Her research focuses on 3 major innovations in receptor pharmacology: allosteric modulation, biased signalling, and bitopic ligand design. Together, these concepts have reshaped approaches to GPCR drug discovery, led to structural breakthroughs, enabled successful commercial translation, and informed international pharmacological standards. Her contributions span foundational science through to industry uptake and regulatory implementation. She is an associate editor of npj Drug Discovery (Nature portfolio journal), a member of the board of the mAChR Nomenclature subcommittee for the International Union of Basic and Clinical Pharmacology, and co-chair of the Neuropharmacology SIG of Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists.

Ritu is a Postdoctoral Research Fellow at the University of Sydney. Her PhD explored digital health technologies for supporting patients with atrial fibrillation and her postdoctoral research work is focused on the accuracy of devices used by Australians to measure their blood pressure at home. Ritu’s research interests are in optimising self-management for those with cardiovascular diseases.

Currently pursuing a PhD in Medicine at Monash University, I am a First Class Honours graduate in Science with a background in industrial laboratory research. My work centers on genetics and genome biology, with a particular focus on advancing our understanding of cardiovascular health. I bring a strong work ethic, adaptability, and a collaborative mindset to every research endeavor, and I thrive in multidisciplinary environments. My commitment to impactful science is reflected in my first-author publication, and I continue to explore novel genomic mechanisms that may inform future therapeutic strategies. Through my academic and professional journey, I aim to contribute meaningful insights to the scientific community and foster innovation in medical research.